Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation

Atherosclerosis

Volumn 194, Issue 1, 2007, Pages 159-168

  Matsuo, Yoshino ^a   Miura, Shin ichiro ^a   Kawamura, Akira ^a   Uehara, Yoshinari ^a   Rye, Kerry Anne ^b,c,d   Saku, Keijiro ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HEART RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Extracellular signal regulated kinases; Reconstituted high density lipoprotein; Sphingosine 1 phosphate; Tube formation

Indexed keywords

2 OLEOYL 1 PALMITOYLPHOSPHATIDYLCHOLINE; APOLIPOPROTEIN A1; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; SPHINGOSINE 1 PHOSPHATE;

ACUTE CORONARY SYNDROME; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL MOTILITY; CELL SURVIVAL; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; ENDOTHELIUM; ENZYME ACTIVATION; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; MACROPHAGE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ATHEROSCLEROSIS; CELL DIVISION; CELLS, CULTURED; CHO CELLS; CHOLESTEROL; CORONARY VESSELS; CRICETINAE; CRICETULUS; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HUMANS; LIPOPROTEINS, HDL; LYSOPHOSPHOLIPIDS; MACROPHAGES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHATIDYLCHOLINES; PROTO-ONCOGENE PROTEINS C-AKT; RAS PROTEINS; SPHINGOSINE;

EID: 34250352903     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.10.020     Document Type: Article

References (38)

1. Gordon D.J., and Rifkind B.M. High-density lipoprotein-the clinical implications of recent studies. N Engl J Med 321 (1989) 1311-1316
2. von Eckardstein A., Nofer J.-R., and Assmann G. Acceleration of reverse cholesterol transport. Curr Opin Cardiol 15 (2000) 348-354
3. Stein O., and Stein Y. Atheroprotective mechanisms of HDL. Atherosclerosis 144 (1999) 285-301
4. Masao T., and Liao J.K. Pleiotropic effects of 3-hydroxy-3-methylglutanyl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol 21 (2001) 1712-1719
5. Linsel-Nitschke P., and Tall A.R. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Dis 4 (2005) 193-205
6. Miyazaki A., Sakuma S., Morikawa W., et al. Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 15 (1995) 1882-1888
7. Eriksson M., Carlson L.A., Miettinen T.A., and Angelin B. Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans. Circulation 100 (1999) 594-598
8. Garber D.W., Datta G., Chaddha M., et al. A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis. J Lipid Res 42 (2001) 545-552
9. Navab M., Anantharamaiah G.M., Hama S., et al. Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation 105 (2002) 290-292
10. Li X., Chyu K.Y., Neto J.R., et al. Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice. Circulation 110 (2004) 1701-1705
11. Van Lenten B.J., Wagner A.C., Anantharamaiah G.M., et al. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide. Circulation 106 (2002) 1127-1132
12. Weng S., Yang B., Saldeen T., et al. Inhibition of arterial thrombus formation by ApoA1 Milano. Arterioscler Thromb Vasc Biol 19 (1999) 378-383
13. Nissen S.E., Tsunoda T., Tuzcu E.M., et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290 (2003) 2292-2300
14. Miura S., Tanigawa H., Matsuo Y., et al. Ras/Raf1-dependent signal in sphingosine-1-phosphate-induced tube formation in human coronary artery endothelial cells. Biochem Biophys Res Comm 306 (2003) 924-929
15. Kluk M.J., and Hla T. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim Biophys Acta 1582 (2002) 72-80
16. Lee M.J., Thangada S., Claffey K.P., et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99 (1999) 301-312
17. Rye K.A., Garrety K.H., and Barter P.J. Changes in the size of reconstituted high density lipoproteins during incubation with cholesteryl ester transfer protein: the role of apolipoproteins. J Lipid Res 33 (1992) 215-224
18. Osborne Jr. J.C. Delipidation of plasma lipoproteins. Meth Enzymol 128 (1986) 213-222
19. Weisweiler P. Isolation and quantitation of apolipoproteins A-I and A-II from human high-density lipoproteins by fast-protein liquid chromatography. Clin Chim Acta 169 (1987) 249-254
20. Matz C.E., and Jonas A. Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J Biol Chem 257 (1982) 4535-4540
21. Rye K.A., and Hime N.J. Evidence that cholesteryl ester transfer protein-mediated reductions in reconstituted high density lipoprotein size involve particle fusion. J Biol Chem 272 (1997) pp.3963-3960
22. Miura S., Fujino M., Matsuo Y., et al. High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 23 (2003) 802-808
23. Miura S., Matsuo Y., and Saku K. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Hypertension 41 (2003) 1118-1123
24. Kleinman H.K., McGarvey M.L., Hassell J.R., et al. Basement membrane complexes with biological activity. Biochemistry 25 (1986) 312-318
25. He H., Venema V.J., Gu X., et al. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem 274 (1999) 25130-25135
26. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 (1997) 4-25
27. Isner J.M., and Losordo D.W. Therapeutic angiogenesis for heart failure. Nat Med 5 (1999) 491-492
28. Kahlon R., Shapero J., and Gotlieb A.I. Angiogenesis in atherosclerosis. Can J Cardiol 8 (1992) 60-64
29. 3. J Clin Invest 113 (2004) 569-581
30. Nofer J.R., Levkau B., Wolinska I., et al. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem 276 (2001) 34480-34485
31. Eliceiri B.P., Paul R., Schwartzberg P.L., et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4 (1999) 915-924
32. Kwon Y.G., Min J.K., Kim K.M., et al. Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J Biol Chem 276 (2001) 10627-10633
33. An S., Zheng Y., and Bleu T. Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5. J Biol Chem 275 (2000) 288-296
34. Kim J.I., Jo E.J., Lee H.Y., et al. Sphingosine 1-phosphate in amniotic fluid modulates cyclooxygenase-2 expression in human amnion-derived WISH cells. J Biol Chem 278 (2003) 31731-31736
35. Gong M., Wilson M., Kelly T., et al. HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner. J Clin Invest 111 (2003) 1579-1587
36. Baranova I.N., Vishnyakova T.G., Bocharov A.V., et al. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J Biol Chem 280 (2005) 8031-8040
37. Rak J., and Kerbel R.S. Ras regulation of vascular endothelial growth factor and angiogenesis. Meth Enzymol 333 (2001) 267-283
38. Kerbel R.S., Viloria-Petit A., Klement G., and Rak J. 'Accidental' anti-angiogenic drugs: anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples. Eur J Cancer 36 (2000) 1248-1257